Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Pfizer Appoints Elif Aral as Regional President for the Middle East, Russia &…
Commenting on the recent appointment, Elif said, "I have had the privilege of witnessing firsthand how Pfizer has evolved and transformed the medical industry for nearly three decades – almost my entire career. Additionally, I have seen how the company's leadership prioritizes diversity, equity, and inclusion, not only for the patients in the markets they serve but also for employees at all levels and regions. I am thrilled to embark on this new chapter with Pfizer and am particularly…
PR Newswire
05/09/2024
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
COPENHAGEN, Denmark, September 5, 2024– Bavarian Nordic A/S (OMX: BAVA) announced today that the Company's share capital has been increased by nominally DKK 7,164,460 as a consequence of employees' exercise of warrants.The capital increase was effected without any pre-emption rights for the existing shareholders of the Company or others. The shares were subscribed for in cash at the following prices per share of nominally DKK 10: 447,869 shares at DKK 146.60, 7,039 shares at DKK 155...
Nasdaq GlobeNewswire
05/09/2024
Capecitabine Market to Reach $0.7 Billion, Globally, by 2033 at 5% CAGR: Allied…
Prime Determinants of Growth Prime Determinants of Growth The global capecitabine market is experiencing growth due to surge in prevalence of cancer. Cancer, a complex and multifaceted disease, has seen a notable increase in incidence rates across various demographics and geographic regions in recent years. According to Colorectal Cancer Alliance, it was reported that each year, about 150, 000 Americans are diagnosed with colorectal cancer. Factors such as aging population, lifestyle...
PR Newswire
05/09/2024
European Commission Grants Orphan Drug Designation for Vivet Therapeutics Gene…
Dr Jean-Philippe Combal, Co-Founder & Chief Executive Officer at Vivet Therapeutics, said: "Early diagnosis and treatment of CTX is crucial to halting disease progression. At present, existing standard of care treatments can only slow or stabilize leukodystrophy, with no cure available. Preclinical data supports VTX-806's potential as an alternative treatment option to stop, or reverse, disease progression over the long-term, or possibly even cure CTX patients. Receiving ODD from the EU…
PR Newswire
05/09/2024
Trading in GN Store Nord shares by board members, executives and associated…
Trading in GN Store Nord shares by board members, executives and associated personsGN Store Nord has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in GN Store Nord made by persons discharging managerial responsibilities in GN Store Nord and/or persons closely associated with them. Details of the person discharging managerial responsibilities/person closely associated NameSøren Jelert Reason for the...
Nasdaq GlobeNewswire
05/09/2024
Build-A-Bear Workshop Celebrates National Teddy Bear Day on 9 September with…
The 9 September celebration of National Teddy Bear Day has become an annual tradition for the well-known experiential retailer that has now sold upwards of 240 million furry friends worldwide and has a stated mission to "add a little more heart to life." In the spirit of that mission, and in honour of National Teddy Bear Day, the philanthropic arm of the company, Build-A-Bear Foundation, will be donating more than 10,000 teddy bears to kids in need. This effort is just one part of the…
PR Newswire
05/09/2024
Statement re Change of Corporate Adviser
DXS INTERNATIONAL PLC(AQSE: DXSP)Change of Adviser DXS International plc (AQSE: DXSP) ("DXS" or the "Company"), the digital clinical decision support company, is pleased to announce that it has appointed Hybridan LLP as its AQSE Corporate Adviser with immediate effect. Hybridan remains AQSE Corporate Broker to the Company. The Directors of DXS accept responsibility for the contents of this announcement.This announcement contains information which, prior to its disclosure…
Nasdaq GlobeNewswire
05/09/2024
Breakthrough Therapy designation for Sanbexin sublingual tablets granted by the…
The Breakthrough Therapy designation is based on the significant improvement in efficacy metrics demonstrated by the sublingual tablets in a previous clinical study. The data from a multicenter, randomized, double-blind, parallel, placebo-controlled Phase III clinical study in China for the treatment of AIS demonstrated that Sanbexin sublingual tablets significantly improved neurological recovery and independent living ability in patients with AIS compared to placebo, meeting the expected…
PR Newswire
05/09/2024
Vivoryon Therapeutics N.V. to Report Half Year 2024 Financial Results on…
Vivoryon Therapeutics N.V. to Report Half Year 2024 Financial Results on September 12, and to Host KOL Event on September 30, 2024Halle (Saale) / Munich, Germany, September 5 , 2024- Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) ( Vivoryon ), a clinical stage company focused on the discovery and development of small molecule medicines to modulate the activity and stability of pathologically altered proteins, today announced that it will host two events in...
Nasdaq GlobeNewswire
05/09/2024
LG TO INTRODUCE EXCITING VISION FOR FUTURE LIVING WITH "LG AI HOME" INNOVATIONS…
Central to LG's Affectionate Intelligence Home is LG ThinQ ON, an advanced AI home hub designed to deliver comfort and convenience tailored to individual preferences. ThinQ ON seamlessly integrates with LG's latest AI appliances, forming the core of the LG AI Home Solution. This system is driven by Affectionate Intelligence, LG's empathetic and caring AI technology. As the AI Home Solution learns more about users' routines, preferences and behaviors over time, it creates a personalized spatial…
PR Newswire
05/09/2024
Global Heparin Market to Reach ~USD 15 Billion by 2030 | DelveInsight
Key Takeaways from the Heparin Market Report Key Takeaways from the Heparin Market Report To read more about the latest highlights related to the heparin market, get a snapshot of the key highlights entailed in the Global Heparin Market Report Heparin Overview Heparin is a widely used anticoagulant medication that helps prevent and treat blood clots. It works by enhancing the activity of antithrombin III, a protein in the blood that inhibits blood clotting factors such as...
PR Newswire
04/09/2024
Chronic Venous Insufficiency Market to Show Immense Growth at a CAGR of 9.5% by…
Key Takeaways from the Chronic Venous Insufficiency Market Report Key Takeaways from the Chronic Venous Insufficiency Market Report Discover which therapies are expected to grab the major chronic venous insufficiency market share @ Chronic Venous Insufficiency Market Report Chronic Venous Insufficiency Overview Chronic venous disease (CVD) is a common condition that affects the venous system, particularly the veins in the lower limbs. It includes a range of venous disorders,...
PR Newswire
04/09/2024
Monthly information on share capital and company voting rights
(Article 223-16 of General Regulation of the French financial markets authority) Listing market: Euronext Growth ISIN code: FR0010425595DateTotal number of shares in the capitalTotal number of voting rights 08/31/2024100,093,63588,029,440 For further information on Cellectis, please contact: Media contact: Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33,
[email protected]
Patricia Sosa Navarro, Chief of Staff to the...
Nasdaq GlobeNewswire
04/09/2024
DBV Technologies to Participate in the H.C. Wainwright 26th Annual Global…
DBV Technologies to Participate in the H.C. Wainwright 26 thAnnual Global Investment Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that Daniel Tassé, Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright 26 thAnnual Global Investment Conference on Monday, September 9, 2024, at 3:00 pm ET, in New York City.A live webcast of the presentation can...
Nasdaq GlobeNewswire
04/09/2024
NANOBIOTIX Announces Two Key Supervisory Board Additions Intended to Further…
Dr. Margaret A. Liu, global expert in vaccines, gene therapy, and cancer immunotherapy; chief executive officer of PAX Therapeutics and member of several boardsMs. Anat Naschitz, proven life science investor and entrepreneur; co-founder of OrbiMed IsraelPARIS and CAMBRIDGE, Mass., Sept.04, 2024(GLOBE NEWSWIRE) --NANOBIOTIX(Euronext: NANO –– NASDAQ: NBTX – the '' Company ''), a late-clinical stage biotechnology company pioneering nanoparticle-based therapeutic approaches to...
Nasdaq GlobeNewswire
04/09/2024
Ipsen - August 2024 - Monthly information relative to the total number of voting…
Monthly information relative to the total number of voting rightsand shares composing the share capital(in accordance with Article L.233-8 II of the French Commercial Code andArticle 223-16 of the General Regulation of theAutorité des Marchés Financiers ) Market: Euronext ParisISIN Code: FR 0010259150 LEI: 549300M6SGDPB4Z94P11 DateTotal number of shares composing the share capitalTotal number of voting rights(1) 31 August 202483,814,526Gross total*...
Nasdaq GlobeNewswire
04/09/2024
VALNEVA - Declaration of shares and voting rights: August 31, 2024
VALNEVADeclaration of shares and voting rightsAugust 31, 2024__________________________________________________________________________________________Company name: VALNEVA Registered office: 6 rue Alain Bombard, 44800 Saint-Herblain (France) Regulated market of Euronext Paris - Compartment B Declaration date: September 4, 2024 Number of sharescomposing the share capital of ValnevaTotal number of voting rights including suspended voting rights* Description of the...
Nasdaq GlobeNewswire
04/09/2024
Autoinjectors Market to Hit USD 3.02 Billion by 2030: Growth Drivers, Key…
Browse in-depth TOC on "Autoinjectors Market" Browse in-depth TOC on "Autoinjectors Market" 527 - Tables75 - Figures382 - Pages Factors Driving Market Growth Key drivers of the autoinjectors market include the increased adoption of these devices due to their ease of use, along with a rise in approvals for biosimilars and biologics. Technological advancements such as Bluetooth connectivity, dose monitoring, adherence tracking, and data sharing with healthcare providers...
PR Newswire
04/09/2024
Medical Foam Market Surges to USD 47.2 Billion by 2030, Propelled by 6.5% CAGR -…
Download PDF Brochure: https://www.verifiedmarketreports.com/download-sample/?rid=433158 Download PDF Brochure: https://www.verifiedmarketreports.com/download-sample/?rid=433158 Browse in-depth TOC on Medical Foam Market 202 - Pages 126 – Tables 37 – Figures Scope of The Report Global Medical Foam Market Overview Market Drivers Fueling Growth in the Medical Foam Market Rising Demand for Advanced Wound Care Products:The growing prevalence of chronic...
PR Newswire
04/09/2024
Refurbished Medical Imaging Equipment Market is expected to generate a revenue…
Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=40275 Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=40275 Browse in-depth TOCon" Global Refurbished Medical Imaging Equipment Market Size " 202 - Pages 126 – Tables 37 – Figures Report Scope Global Refurbished Medical Imaging Equipment Market Overview Cost-Effectiveness and Affordability : One of the main factors contributing to the...
PR Newswire
04/09/2024
Charles River and Insightec Announce Strategic Collaboration to Advance…
"Our collaboration with Insightec represents a significant step forward in advancing neuroscience research," said ProfessorJulie Frearson, PhD, Senior Vice President and Chief Scientific Officer at Charles River. "As we look toward the future of drug discovery, we recognize that technology will be a cornerstone of innovation. The integration of focused ultrasound technology into our preclinical services will enhance the precision and effectiveness of therapeutic delivery...
PR Newswire
04/09/2024
Pharma Targeting celebrates a year of growth and milestones amid industry…
Founded by Anil Kumar, an immunologist turned entrepreneur, Pharma Targeting - part of The Targeting Group - partners with global clients to deliver comprehensive business development strategies using a revolutionary 3 Step Model, which identifies and secures high-value, first-to-market opportunities. Their approach is designed to ensure clients get in front of 70+ decision-makers annually, whilst saving both time and money. Founded by Anil Kumar, an immunologist turned entrepreneur…
PR Newswire
04/09/2024
Signant Health expands availability of its eClinical solutions by joining IQVIA…
One such technology solution that will appear on the One Home for Sites platform is Signant SmartSignals® Unified Platform, itself a fully integrated solution consisting of eCOA, EDC, RTSM, eConsent, and telemedicine. One such technology solution that will appear on the One Home for Sites platform is Signant SmartSignals® Unified Platform, itself a fully integrated solution consisting of eCOA, EDC, RTSM, eConsent, and telemedicine. "We are very pleased to have our Unified Platform now...
PR Newswire
04/09/2024
Phesi Receives Frost & Sullivan's Global Enabling Technology Leadership Award…
Frost & Sullivan presents this annual award to a company that has developed pioneering technology that not only enhances current products but enables the development of new products and applications. Frost & Sullivan presents this annual award to a company that has developed pioneering technology that not only enhances current products but enables the development of new products and applications. Aarti Siddhesh Chitale, healthcare senior industry analyst at Frost & Sullivan,...
PR Newswire
04/09/2024
Altri Comunicati
